0001209191-22-011299.txt : 20220218 0001209191-22-011299.hdr.sgml : 20220218 20220218163311 ACCESSION NUMBER: 0001209191-22-011299 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220216 FILED AS OF DATE: 20220218 DATE AS OF CHANGE: 20220218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Luthringer Remy CENTRAL INDEX KEY: 0001610384 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36517 FILM NUMBER: 22653338 MAIL ADDRESS: STREET 1: C/O MINERVA NEUROSCIENCES, INC. STREET 2: 1601 TRAPELO ROAD, SUITE 286 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Minerva Neurosciences, Inc. CENTRAL INDEX KEY: 0001598646 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260784194 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 286 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-600-7373 MAIL ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 286 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-16 0 0001598646 Minerva Neurosciences, Inc. NERV 0001610384 Luthringer Remy C/O MINERVA NEUROSCIENCES, INC. 1601 TRAPELO ROAD, SUITE 286 WALTHAM MA 02451 1 1 0 0 CEO Employee Stock Option (right to buy) 0.791 2022-02-16 4 A 0 505000 0.00 A 2032-02-15 Common Stock 505000 505000 D The option vests 25% on February 16, 2023 and then in equal quarterly installments over 3 years thereafter. /s/ Ryan Sansom, Attorney-in-Fact 2022-02-18